EUVIMEDEUVIMED entdecken
Open Access

Biological Evaluation of the Antibacterial Retinoid CD437 in Cutibacterium acnes Infection

Xiao-Wen Huang, Wen Pan iD, Mei-Zhen Zhong, Yashpal Singh Chhonker, Andrew D Steele, Colleen E Keohane, Biswajit Mishra, Lewis Oscar Felix Raj Lucas, Daryl J Murry iD, Frederick M Ausubel, William M Wuest, Chang-Xing Li und 1 weitere

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01679-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Xiao-Wen Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Retinoids, Acne Vulgaris. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acne vulgaris is a complex skin disease involving infection by Cutibacterium acnes , inflammation, and hyperkeratinization. We evaluated the activity of the retinoid 6-[3-(adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) and 16 other retinoid analogs as potential anti- C. acnes compounds and found that CD437 displayed the highest antimicrobial activity with an MIC against C. acnes (ATCC 6919 and HM-513) of 1 μg/mL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoidsAcne VulgarisMiceAnimalsHumansCytokinesAnti-Bacterial AgentsInflammationPropionibacterium acnes

Stichwörter der Autor:innen

CD437acneinflammationirritation

Substanzen

RetinoidsCytokinesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Division of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Chemistry, Emory University, Atlanta, Georgia, USA.
  • Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Wen Pan, Daryl J Murry, Eleftherios Mylonakis

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Huang, X. W., Pan, W., Zhong, M. Z., Chhonker, Y. S., Steele, A. D., Keohane, C. E., Mishra, B., Felix Raj Lucas, L. O., Murry, D. J., Ausubel, F. M., Wuest, W. M., Li, C. X., & Mylonakis, E. (2023). Biological Evaluation of the Antibacterial Retinoid CD437 in Cutibacterium acnes Infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01679-22

Vancouver

Huang XW, Pan W, Zhong MZ, Chhonker YS, Steele AD, Keohane CE, et al. Biological Evaluation of the Antibacterial Retinoid CD437 in Cutibacterium acnes Infection. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01679-22

BibTeX
@article{Huang2023,
  author = {Huang, Xiao-Wen and Pan, Wen and Zhong, Mei-Zhen and Chhonker, Yashpal Singh and Steele, Andrew D and Keohane, Colleen E and Mishra, Biswajit and Felix Raj Lucas, Lewis Oscar and Murry, Daryl J and Ausubel, Frederick M and Wuest, William M and Li, Chang-Xing and Mylonakis, Eleftherios},
  title = {Biological Evaluation of the Antibacterial Retinoid CD437 in Cutibacterium acnes Infection},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01679-22}
}
Kostenlos starten →